We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Aquacel Versus Iodoform Gauze for Filling Abscess Cavity Following Incision and Drainage

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00984022
First Posted: September 24, 2009
Last Update Posted: October 4, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Maricopa Integrated Health System
Results First Submitted: August 11, 2010  
Study Type: Interventional
Study Design: Allocation: Randomized;   Intervention Model: Parallel Assignment;   Masking: None (Open Label);   Primary Purpose: Treatment
Conditions: Abscess
Cellulitis
Interventions: Device: Type of dressing - Iodoform
Device: Type of dressing - Aquacel

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
  Description
Iodoform Dressing Iodoform dressing for cutaneous abscess. Iodoform packing strips provided by Kendall, Curity, Tyco Healthcare Group LP, Mansfield, MA. Placed in the cavity after incision and drainage.
Aquacel Dressing Aquacel dressing for cutaneous abscess. Aquacel Ag ribbons (Conva Tec Ltd., Skillman, NJ). Placed in the cavity after incision and drainage.

Participant Flow:   Overall Study
    Iodoform Dressing   Aquacel Dressing
STARTED   43   49 
COMPLETED   33   35 
NOT COMPLETED   10   14 
Lost to Follow-up                10                14 



  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
  Description
Iodoform Dressing Iodoform dressing for cutaneous abscess. Iodoform packing strips provided by Kendall, Curity, Tyco Healthcare Group LP, Mansfield, MA. Placed in the cavity after incision and drainage.
Aquacel Dressing Aquacel dressing for cutaneous abscess. Aquacel Ag ribbons (Conva Tec Ltd., Skillman, NJ). Placed in the cavity after incision and drainage.
Total Total of all reporting groups

Baseline Measures
   Iodoform Dressing   Aquacel Dressing   Total 
Overall Participants Analyzed 
[Units: Participants]
 43   49   92 
Age 
[Units: Participants]
Count of Participants
     
<=18 years      0   0.0%      0   0.0%      0   0.0% 
Between 18 and 65 years      43 100.0%      49 100.0%      92 100.0% 
>=65 years      0   0.0%      0   0.0%      0   0.0% 
Age 
[Units: Years]
Mean (Standard Deviation)
 36.8  (12.6)   39.2  (11.6)   38.0  (12.0) 
Sex: Female, Male 
[Units: Participants]
Count of Participants
     
Female      15  34.9%      16  32.7%      31  33.7% 
Male      28  65.1%      33  67.3%      61  66.3% 
Region of Enrollment 
[Units: Participants]
     
United States   43   49   92 


  Outcome Measures
  Show All Outcome Measures

1.  Primary:   Number of Participants Who Experienced a 30% or Greater Reduction in Surface Area of Abscess   [ Time Frame: 2 weeks ]

2.  Secondary:   Change in Patient Rating of Pain   [ Time Frame: Baseline and 2 weeks ]

3.  Secondary:   Number of Participants Who Experienced a 30% or Greater Reduction in Surface Area of Cellulitis.   [ Time Frame: 2 weeks ]


  Serious Adverse Events


  Other Adverse Events


  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.


  More Information
  Hide More Information

Certain Agreements:  
All Principal Investigators ARE employed by the organization sponsoring the study.


Results Point of Contact:  
Name/Title: David Drachman
Organization: Maricopa Integrated Health System
phone: 602-344-5161
e-mail: david.drachman@mihs.org



Responsible Party: Maricopa Integrated Health System
ClinicalTrials.gov Identifier: NCT00984022     History of Changes
Other Study ID Numbers: 2008-003
First Submitted: September 22, 2009
First Posted: September 24, 2009
Results First Submitted: August 11, 2010
Results First Posted: October 27, 2010
Last Update Posted: October 4, 2017